| Trial ID: | L0954 |
| Source ID: | NCT00452166
|
| Associated Drug: |
Rosiglitazone
|
| Title: |
Rosiglitazone and Insulin Resistance in Renally Impaired Patients
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Insulin Resistance
|
| Interventions: |
DRUG: rosiglitazone
|
| Outcome Measures: |
Primary: Insulin sensitivity, 12 weeks | Secondary: inflammation, 12 weeks|lipid profile, 12 weeks|bone density, 12 weeks|body composition, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Leiden University Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-04
|
| Completion Date: |
2008-05
|
| Results First Posted: |
|
| Last Update Posted: |
2008-10-02
|
| Locations: |
LUMC, Leiden, Netherlands
|
| URL: |
https://clinicaltrials.gov/show/NCT00452166
|
